Infectious Diseases

Sterne Kessler’s infectious disease team helps clients protect and defend the drug and vaccine innovations they make in the fight against infectious diseases.

The infectious diseases team integrates knowledge in small molecule chemistry, biotechnology, pathogenesis, immunology and treatment methods on behalf of companies and organizations innovating in the infectious diseases sector.

Our integrated team is perfectly positioned to provide strategic IP services to companies and organizations innovating in the infectious diseases sector. Our services include patent portfolio strategy, freedom-to-operate analyses (including design around counseling and market clearance for diagnostics and treatments), patentability analyses, patent procurement, licensing, cooperative research and development agreements, and litigation (including at the USITC).

We have experience in areas such as:

  • Vaccines
  • Adjuvants
  • Anti-infectives including:
    • Antivirals
    • Antibiotics and other antibacterials
    • Biodefense
    • Virulence markers
  • Personalized medicine
  • Diagnostic assays
  • Biologics

Related Resources

Speaking Engagement

2023 Focus on Pharma

April 14, 2023 8:30 AM - 6:00 PM PST

Press Release

Sterne Kessler Director Eldora L. Ellison Appointed to Advisory Council for the CAFC

Sterne, Kessler, Goldstein & Fox September 30, 2022

In the News

Gilead Settles HIV Drugs Patent Suit on Eve of Bench Trial

Law360 September 12, 2022

In the News

New Trustees to Join Cornell Board

Cornell Chronicle June 2, 2022

Speaking Engagement

Chairman’s Opening Address and Closing Remarks

May 11, 2022 9:00 AM - 4:45 PM PST

Press Release

Sterne Kessler Named Among 2021 “Best Law Firms” by Best Lawyers

Sterne, Kessler, Goldstein & Fox November 6, 2020

Webinar

Drug Development Pathway Series: Intellectual Property Workshop

October 28, 2020 4:00 PM - 5:00 PM PST

Press Release

Firm and Seven Directors Recognized in 2020 LMG Life Sciences Rankings

Sterne, Kessler, Goldstein & Fox P.L.L.C. October 6, 2020

Bylined Articles

Joint Research Considerations As Biotech Responds To Virus

Law360 April 27, 2020

Bylined Articles

Vaccine R&D and Economic Impact of COVID-19 Pandemic

ACC Docket April 22, 2020

Webinar

Innovation in the Age of COVID-19

April 14, 2020 11:00 AM - 1:00 PM PST

In the News

Webinar on Innovation in Age of COVID-19

Patent Docs April 11, 2020

Bylined Articles

Patenting Compounds, Compositions, and Methods for Viral Infections

Bloomberg Law March 11, 2020

Speaking Engagement

Pharma IPR Conference 2020

March 4, 2020 12:00 AM - 11:59 PM PST

Bylined Articles

Vaccine IP Under Microscope With Coronavirus Outbreak

Law360 March 4, 2020

Press Release

Director Eldora L. Ellison, Ph.D. Receives Top Honor at 2019 LMG Life Sciences Awards

Sterne, Kessler, Goldstein & Fox P.L.L.C September 23, 2019

Speaking Engagement

Microbiome R&D and Business Collaboration Forum: USA

October 29, 2018 12:00 AM - 11:59 PM PST

In the News

Biologic Fights Drive PTAB Drug Challenges To Record High

Law360 February 8, 2018